Question 5

The following blood tests were obtained from a trauma patient with stable haemodynamic parameters on day 3 of ICU.

Parameter

Patient                           

Reference                  

Haemoglobin

63 g/L*

130-175

Haematocrit

0.22*

0.40-0.52

MCV

98 fL

80-99

MCH

29 pg

27-33

Platelets

496 x 109/L*

150-400

WBC

20.0 x 109/L*

4-11

Neutrophils

13.6 x 109/L *

1.9-7.5

Lymphocytes

2.2 x 109/L

1.0-4.0

Meta/myelocytes

1.3 x 109/L*

0.0-0.06

Nucleated RBC

0.1 x 109/L*

Reticulocytes

162 x 109/L*

10-100

Fibrinogen

4.3 g/L*

1.5-4.0

Sodium

142 mmol/L

135-145

Potassium

3.8 mmol/L

3.5-5.2

Urea

15.1 mmol/L*

3.2-7.7

Creatinine

115 µmol/L*

50-110

Glucose

9.6 mmol/L*

3.5-7.7

Calcium

2.0 mmol/L*

2.2-2.6

Phosphate

0.9 mmol/L

0.8-1.5

Magnesium

1.0 mmol/L

0.6-1.2

Protein

51 g/L*

64-83

Albumin

24 g/L*

32-48

Bilirubin

79 µmol/L*

2-20

Bilirubin (conjugated)         

47 µmol/L*

0-5

Alkaline Phosphatase

58 U/L

30-150

Gamma GT

507 U/L*

10-50

AST

287 U/L*

10-50

ALT

101 U/L*

0-40

LDH

282 U/L*

110-120

CRP

139mg/L*

<5

a)    Outline and explain the key abnormalities (4 marks)

b)    Discuss the additional investigations you would request to assess anaemia in this patient (3 marks)
c)    Describe the management of anaemia in this patient (3 marks)
 


 

[Click here to toggle visibility of the answers]

College comments

Syllabus topic/section: 2.1.11 Haematological and Oncological Intensive Care 2.1.13 Trauma Intensive Care

Discussion: 

A structured approach was necessary here and answers that were poorly structured did not score as well. Candidates who did well noted the need for explanation of the key abnormalities, not simply an outline as directed in the stem. Similarly, part (b) called for a discussion of the additional investigations rather than simply providing a list.

Candidates are reminded to read the question carefully and with particular reference to the glossary terms to ensure they have the best opportunity to include the relevant information in their answers. The rubric is provided to aid the candidate's future study.
 

Rubric

Below standard

At standard

Above standard

a)

Outline and explain the key abnormalities

(4 marks)

Limited integration or no supporting explanation of key abnormalities (as per at standard)

Stipulating anaemia without any classification of anaemia

Integration and explanation to cover minimum of

  • Some classification of anaemia (normochromic, normocytic)
  • Inflammation/infection
  • Haemolysis
  • Likely alcohol related liver disease

Consider at standard mark for otherwise above standard answer which omits one of minimum at standard criteria

As at standard PLUS Integration and explanation of all/majority of abnormalities

  • Greater depth than minimum standard
  • Marrow precursors
  • Type of haemolysis (intravascular verses extravascular)
  • Liver dysfunction Important negatives that assist integration/explanation

0-1.5 marks

2.0-2.5 marks

3.0-4.0 marks

b)

Discuss the additional investigations you would request to assess anaemia in this patient

(3 marks)

List without discussion

Omission of one or more of key topics as per at standard

General principles that might guide subsequent subspecialty discussions

  • Haemoglobin (Hb) production (B12, folate)
  • Hb loss – ongoing bleeding
  • Hb destruction – blood film, Red cell antibody screen, DAT, infection etc (extensive list NOT required)

As at standard PLUS

Detailed explanation of appropriate tests to support and refute potential causes.

Detailed investigations for haemolysis assessment

Consider at standard mark if above standard answer and omission of Hb production

0-1 marks

1.5 marks

2.0-3.0 marks

c)

Describe the management of anaemia in this patient

(3 marks)

Poorly structured with generic (not specific to this case) anaemia management answer.

Omission of one or more of the minimum criteria for at standard, noting the comments regarding discretion

0-1 marks

Minimum should cover Stop loss

  • Bleeding and haemostasis

Remove precipitant

  • infection or stop culprit meds

Hb replacement

  • After repeat crossmatch or haem review)

Use discretion based on answers given in question “b” but broad principles of loss, replacement and some basic disease specific management is a minimum

1.5 marks

As at standard PLUS Greater detail and some question specific rather than generic management AND

Detailed disease specific management (when, why and how)

  • Plasma exchange, immunosuppression, splenectomy etc

2.0-3.0 marks

Interpretation

"Outline" and "explain" is a strange mixture of exam vocabulary terms, as surely "explain" alone would have been enough. And which abnormalities are "key", versus those which are non-key? The rubric offers some answers.

Without too much effort, we can see the patient is clearly haemolysing.

  • There is anaemia. Hb is 64
  • The MCV is at the borders of elevated; these cells are satisfyingly plump. But you would be forced to describe them as normocytic and normochromic.
  • The CRP, fibrinogen, platelets and WCC are elevated (neutrophilia is the dominant feature), suggesting some kind of proinflammatory state
  • The presence of metamyelocytes (immature neutrophils) suggests bone marrow stress, with these white cells rushed to production
  • Nucleated RBCs and reticulocytes similarly suggests a pressure to produce cells, suggesting there is a state of accelerated erythropoiesis
  • The electrolytes are trivially deranged; only calcium is marginally low, which suggests that it may have been consumed in clot production (but there are numerous other possibilities)
  • Urea and creatinine are elevated, with a disproportionally higher urea, suggestive of either  accelerated protein catabolism or a volume-depleted state (urea:creatinine ratio in mmol:µmol is 0.13, where anything over 0.1 is considered to be consistent with pre-renal causes)
  • The serum proteins are depressed, which is totally on brand for anybody with critical illness, and is probably a "non-key abnormality"
  • The conjugated bilirubin is lower than the total bilirubin, which suggests a significant proportion of the bilirubin is unconjugated, meaning that cholestasis is not responsible for this hyperbilirubinaemia
  • The LFTs are deranged in a pattern that is not entirely consistent with cholestasis, and noteably the LDH is raised, which supports the idea that haemolysis is occurring. 

Judging by the rubric, this was all unnecessary, and the most important elements were:

  • Normocytic normochromic anaemia
  • Haemolysis, suggested by raised LDH, conjugated/unconjugated bilirubin ratio, presence of reticulocytes and nucleated RBCs
  • Inflammation or infection, suggested by raised CRP, fibrinogen, leukocytosis
  • Bone marrow stress (left shift of neutrophils)
  • AST: ALT ratio > 2:1 and raised GGT, consistent with alcohol-related liver disease 
  • Pre-renal AKI (urea:creat >0.1)
  • Hypoalbuminaemia consistent with critical illness
  • Normal phosphate, suggesting that rhabdomyolysis is not the source for LHD AST and renal dysfunction

This 69-word answer would have fit within the 4-mark timeframe and would have hopefully satisfied the pickiest of examiners.  Contrary to the rubric, it would have been impossible for the candidates to discriminate between intravascular and extravascular haemolysis here, as this would require further investigations. 

b) 

"Discuss" here suggests that advantages, disadvantages and controversies were sought, which would have been hard to do in three minutes. In any case, the investigations for anaemia are largely uncontroversial. "Discuss" here probably meant "include your rationale for the investigations", which should probably have looked something like this:

  • Haemoglobin production
    • Iron studies, B12, folate
    • Not likely to yield the cause of the anaemia, but will be useful to guide therapy to correct it
  • Blood loss
    • examination (eg. drains), CT of the injured areas, endoscopy, angiography
    • They told us the patient was haemodynamically stable, but that does not exclude a slow ooze from abrasions or oesophageal varices
  • Haemolysis
    • DAT, blood film, haptoglobin, RBC antigen chimaerism (eg. following a transfusion of uncrossmatched or incorrectly matched blood)
    • A specific review of the post-trauma transfusion history, looking for massive transfusion and/or a history of rushed matching or uncrossmatched O-negative transfusion
    • Rapid fluorescent spot test and methaemoglobin level for G6PD

c)

The management of this anaemia would have been dependent on the kind of anaemia you convinced yourself this was, on the basis of investigations in b). Some sort of broad answer to cover all possibilites would have had to look like this:

  • Assure that haemostasis is achieved
  • Exclude transfusion complications and assure correct matching, and then transfuse red cells to achieve a haemoglobin of >70g/L
  • Exclude anaemia of chronic inflammation and infection, and then replace haematinics to reinforce erythropoiesis (iron infusion, B12 and folate replacement)
  • If an autoimmune cause of the anaemia is revealed, the management would differ depending on the cause, and could consist of:
    • Corticosteroids and/or splenectomy for warm haemolysis
    • Rituximab for cold haemolysis
    • Plaspmapheresis for acute fulminant antibody-mediated haemolysis
    • Eculizumab for atypical HUS

References

Zeerleder, S. "Autoimmune haemolytic anaemia-a practical guide to cope with a diagnostic and therapeutic challenge." Neth J Med 69.4 (2011): 177-84.

Gehrs, Bradley C., and Richard C. Friedberg. "Autoimmune hemolytic anemia."American journal of hematology 69.4 (2002): 258-271.

Birgens, Henrik, et al. "A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia." British journal of haematology 163.3 (2013): 393-399.

Lechner, Klaus, and Ulrich Jäger. "How I treat autoimmune hemolytic anemias in adults." Blood 116.11 (2010): 1831-1838.

Salama, A., and B. Mayer. "Diagnostic pitfalls of drug-induced immune hemolytic anemia." Immunohematology 30.2 (2014): 80-4.

Zantek, Nicole D., et al. "The direct antiglobulin test: a critical step in the evaluation of hemolysis." American journal of hematology 87.7 (2012): 707-709.

Ma, Kim, and Stephen Caplan. "Refractory IgG Warm Autoimmune Hemolytic Anemia Treated with Eculizumab: A Novel Application of Anticomplement Therapy." Case reports in hematology 2016 (2016).

Pignon, Jean‐Michel, Emmanuelle Poirson, and Henri Rochant. "Danazol in autoimmune haemolytic anaemia." British journal of haematology 83.2 (1993): 343-345.

Beutler, Ernest. "G6PD deficiency." Blood 84.11 (1994): 3613-3636.

Frank, Jennifer E. "Diagnosis and management of G6PD deficiency." American family physician 72.7 (2005): 1277-1282.

Howes, Rosalind E., et al. "G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map." PLoS medicine 9.11 (2012): e1001339.

Luzzatto, Lucio, and Elisa Seneca. "G6 PD deficiency: a classic example of pharmacogenetics with on‐going clinical implications." British journal of haematology 164.4 (2014): 469-480.

 Clark, Byron B., Robert W. Morrissey, and Dorothy Blair. "Relation of methemoglobin to hemolysis." Blood 6.6 (1951): 532-543.

Ata, Fateen, et al. "Favism Induced Methemoglobinemia in G6DP Deficient Patients: Case Series and Review of Literature." Blood 136.1 (2020): 11-12.